Amae Health Announces $25 Million Series B to Advance Toward a Cure for Severe Mental Illness
More than 15 million Americans live with severe mental illness (SMI) and remain stuck in a cycle of crisis care. Amae Health, a Public Benefit Corporation (PBC) and leader in outpatient treatment for SMI, today announced a $25 million pre-empted Series B financing, bringing total funding to more than $50 million, to transform how these conditions are understood, treated, and ultimately cured. The round was led by Altos Ventures with participation from all existing investors, including Quiet Capital, Bling Capital, Cedars-Sinai Ventures, Healthier Capital, and 8VC.
